Homocysteine is associated with severity of microvasculopathy in sickle cell disease patients.

MLA

Samarron, Sandra L., et al. “Homocysteine Is Associated with Severity of Microvasculopathy in Sickle Cell Disease Patients.” British Journal of Haematology, vol. 190, no. 3, Aug. 2020, pp. 450–57. EBSCOhost, https://doi.org/10.1111/bjh.16618.

APA

Samarron, S. L., Miller, J. W., Cheung, A. T., Chen, P. C., Lin, X., Zwerdling, T., Wun, T., & Green, R. (2020). Homocysteine is associated with severity of microvasculopathy in sickle cell disease patients. British Journal of Haematology, 190(3), 450–457. https://doi.org/10.1111/bjh.16618

Chicago

Samarron, Sandra L., Joshua W. Miller, Anthony T. Cheung, Peter C. Chen, Xin Lin, Theodore Zwerdling, Ted Wun, and Ralph Green. 2020. “Homocysteine Is Associated with Severity of Microvasculopathy in Sickle Cell Disease Patients.” British Journal of Haematology 190 (3): 450–57. doi:10.1111/bjh.16618.